Durvalumab vs Loratadine

Durvalumab vs Loratadine: Overview

This comparison examines the pharmacological differences between Durvalumab and Loratadine.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Loratadine: Second-generation H1 antihistamine with minimal CNS effects.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Loratadine — 8 hours.

Chemical Properties

Molecular Formula: Loratadine — C22H23ClN2O2.

Molecular Weight: Loratadine — 382.8800 g/mol.

Type: Durvalumab — Antibody; Loratadine — Small molecule.